The post Bitwise updates Hyperliquid ETF filing to include BHYP ticker and fee appeared on BitcoinEthereumNews.com. Key Takeaways Bitwise disclosed the BHYP tickerThe post Bitwise updates Hyperliquid ETF filing to include BHYP ticker and fee appeared on BitcoinEthereumNews.com. Key Takeaways Bitwise disclosed the BHYP ticker

Bitwise updates Hyperliquid ETF filing to include BHYP ticker and fee

2025/12/15 23:07

Key Takeaways

  • Bitwise disclosed the BHYP ticker and a 0.67% fee for its Hyperliquid ETF in a recent filing.
  • The updated filing includes an 8a provision, suggesting the ETF launch may be imminent.

Bitwise plans to list its Hyperliquid ETF on NYSE Arca under the ticker symbol BHYP and charge an annual management fee of 0.67%, the asset manager revealed in its updated S-1 filing.

According to Bloomberg ETF analyst Eric Balchunas, the proposed Hyperliquid ETF now meets all key launch requirements, including Form 8-A registration, signaling that a launch is imminent.

Bitwise led the push for SEC approval of an ETH tracking Hyperliquid’s HYPE coin, followed later by 21shares.

The development comes as fund managers increasingly offer investors diversified crypto investment options, with many launches in the past two months providing exposure to assets like Solana, XRP, Dogecoin, Litecoin, and HBAR.

Source: https://cryptobriefing.com/bitwise-hyperliquid-etf-bhyp/

Market Opportunity
The Official 67 Coin Logo
The Official 67 Coin Price(67)
$0.010078
$0.010078$0.010078
-11.13%
USD
The Official 67 Coin (67) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.